Article info
Neurodegeneration
Original research
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s disease
- Correspondence to Professor Rimona Sharon Weil; r.weil{at}ucl.ac.uk
Citation
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s disease
Publication history
- Received January 23, 2024
- Accepted March 27, 2024
- First published June 11, 2024.
Online issue publication
August 16, 2024
Article Versions
- Previous version (11 June 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.